- Home
- BHST vs OKYO Comparison
BHST vs OKYO Comparison
Compare BHST & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BHST | OKYO |
|---|---|---|
| Founded | 2007 | 2007 |
| Country | Canada | United Kingdom |
| Employees | 89 | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.9M | 81.3M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | BHST | OKYO |
|---|---|---|
| Price | $2.90 | $1.54 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $10.00 | $6.33 |
| AVG Volume (30 Days) | 27.4K | ★ 62.9K |
| Earning Date | 05-15-2026 | 07-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $146.27 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.75 | $1.42 |
| 52 Week High | $12.80 | $3.35 |
Technical Indicators
Market Signals| Indicator | BHST | OKYO |
|---|---|---|
| Relative Strength Index (RSI) | 34.31 | 47.49 |
| Support Level | $2.75 | $1.47 |
| Resistance Level | $3.47 | $1.72 |
| Average True Range (ATR) | 0.24 | 0.09 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 18.27 | 56.52 |
Price Performance
Historical ComparisonAbout BHST BioHarvest Sciences Inc.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.